Pricing Log in Create free account

Sarepta Therapeutics, Inc. (SRPT) vs Vir Biotechnology, Inc. (VIR)

Sarepta Therapeutics, Inc. and Vir Biotechnology, Inc. are both Biotechnology companies. Sarepta Therapeutics, Inc. and Vir Biotechnology, Inc. are of similar size ($1.9B and $1.9B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,696.0% against −19.0%. Sarepta Therapeutics, Inc. has the higher net margin (−5.86% vs −61.0%) and the higher return on invested capital (−2.03% vs −30.3%). Across the 18 metrics below, Sarepta Therapeutics, Inc. leads on 13 and Vir Biotechnology, Inc. on 5.

Valuation

Metric SRPT VIR Biotechnology median
P/E n/m n/m 10.60
P/S 0.96 6.81 9.40
P/B 1.23 2.30 2.13
Price to free cash flow 11.07 n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.95 5.29 9.02
Earnings yield (6.21%) (10.24%) (32.88%)
Free cash flow yield 9.04% (6.88%) (23.13%)

Profitability

Metric SRPT VIR Biotechnology median
Gross margin 0.00% 99.99% 68.51%
Operating margin (2.50%) (69.82%) 0.00%
Net margin (5.86%) (61.03%) 0.00%
Free cash flow margin 9.02% (46.87%) 0.00%
Return on equity (8.05%) (21.84%) (51.96%)
Return on assets (3.44%) (17.34%) (46.06%)
Return on invested capital (2.03%) (30.32%) 0.00%

Growth

Metric SRPT VIR Biotechnology median
Revenue growth (TTM) (18.95%) 1,695.96% 6.76%
EPS growth (last fiscal year) (404.70%) 17.49% 29.88%
Revenue growth, 5-year CAGR 32.41% (2.14%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SRPT VIR Biotechnology median
Debt to equity 0.56 0.00 0.00
Current ratio 3.46 6.30 4.97
Net debt to EBITDA 0.17 1.02 1.01

Dividend

Metric SRPT VIR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SRPT VIR Biotechnology median
Market cap 1.86b 1.86b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack